Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS)
CNY 14.27
(0.35%)
CNY 14.27
(0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.05 Billion | 995.93 Million | 908.29 Million | 701.1 Million | 925.72 Million | 636.39 Million |
| Net Income | 536.73 Million | 441.91 Million | 324.35 Million | 274.02 Million | 516.51 Million | 437.6 Million |
| Depreciation & Amortization | 190.74 Million | 189.83 Million | 187 Million | 159.58 Million | 165.92 Million | 157.65 Million |
| Deferred income taxes | -30.26 Million | 808.6 Thousand | 917.48 Thousand | -982.56 Thousand | -7.9 Million | -32.05 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 343.54 Million | 362.22 Million | 385.96 Million | 246.78 Million | 206.65 Million | -3.25 Million |
| Other non-cash items | 52.99 Million | -14.19 Million | 10.97 Million | 20.7 Million | 36.63 Million | 44.38 Million |
| Investing Cash Flow | -555.1 Million | -163.94 Million | -296.75 Million | -72.92 Million | -443.01 Million | -328.09 Million |
| Investments in PPE | -297.48 Million | -211.08 Million | -171.52 Million | -190.32 Million | -490.05 Million | -315.73 Million |
| Acquisitions | 2.06 Million | 25.91 Million | 200.74 Million | 190.72 Million | 531.14 Million | 316.89 Million |
| Investment purchases | -1.31 Billion | -900 Million | -1.26 Billion | -686.64 Million | -503.11 Million | -308.75 Million |
| Sales/Maturities of investments | 1.05 Billion | 925.23 Million | 1.1 Billion | 803.63 Million | 509.06 Million | 295.21 Million |
| Other Investing Activities | 1.00 | -3.99 Million | -171.52 Million | -190.32 Million | -490.05 Million | -315.73 Million |
| Financing Cash Flow | -129.81 Million | -168.28 Million | -442.91 Million | -267.6 Million | -451.62 Million | -231.86 Million |
| Debt repayment | - | -234.5 Million | -645.5 Million | -1.14 Billion | -1.68 Billion | -2.37 Billion |
| Dividends payments | -128.5 Million | -2.48 Million | -11.05 Million | -47.43 Million | -47.43 Million | -81.68 Million |
| Common Stock Repurchased | -3.8 Million | - | -179.99 Million | - | -134.99 Million | -115 Million |
| Common Stock Issuance | 4.85 Million | - | 179.99 Million | - | 134.99 Million | - |
| Other Financing Activities | -2.35 Million | 68.69 Million | 213.64 Million | 942.31 Million | 1.32 Billion | 2.22 Billion |
| Accounts receivables | 411.42 Million | -37.17 Million | 360.35 Million | 486.19 Million | 38.19 Million | 64.48 Million |
| Accounts payables | -56.23 Million | 402.81 Million | -15.22 Million | -139.21 Million | 208.92 Million | 5.19 Million |
| Inventory | -11.64 Million | -4.22 Million | 39.92 Million | -99.2 Million | -32.55 Million | -44.46 Million |
| Other working capital | -1.00 | 808.6 Thousand | 917.48 Thousand | -982.56 Thousand | -7.9 Million | 41.21 Million |
| Cash at beginning of period | 1.6 Billion | 937.43 Million | 768.81 Million | 408.24 Million | 377.16 Million | 295.34 Million |
| Cash at end of period | 1.96 Billion | 1.6 Billion | 937.43 Million | 768.81 Million | 408.24 Million | 371.77 Million |
| Capital Expenditure | -297.48 Million | -211.08 Million | -171.52 Million | -190.32 Million | -490.05 Million | -315.73 Million |
| Effect of forex changes on cash | 61.77 Thousand | 151.13 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 367.97 Million | 663.86 Million | 168.62 Million | 360.57 Million | 31.07 Million | 76.42 Million |
| Free Cash Flow | 758.31 Million | 784.85 Million | 736.77 Million | 510.78 Million | 435.66 Million | 320.66 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 91.72 Million | 117.37 Million | 148.04 Million | 536.73 Million | 187.2 Million | 73.8 Million |
| Depreciation & Amortization | - | 48.3 Million | 48.3 Million | 190.74 Million | 47.99 Million | -92.57 Million |
| Deferred income taxes | - | - | - | -30.26 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -65.31 Million | - | 343.54 Million | 399.77 Million | -376.05 Million |
| Other non-cash items | 129.2 Million | 122.87 Million | 58.51 Million | 52.99 Million | -359.49 Million | 717.86 Million |
| Investing Cash Flow | -379.76 Million | 151.52 Million | -105.48 Million | -555.1 Million | 201.38 Million | -671.9 Million |
| Investments in PPE | -78.92 Million | -107.71 Million | -123.27 Million | -297.48 Million | -57.7 Million | -156.5 Million |
| Acquisitions | 16.65 Thousand | 19.24 Million | 0.58 | 2.06 Million | 1.65 Million | 134.92 Thousand |
| Investment purchases | -610 Million | -500 Million | -500 Million | -1.31 Billion | -355 Million | -825 Million |
| Sales/Maturities of investments | 309.14 Million | 740 Million | 517.69 Million | 1.05 Billion | 612.42 Million | 309.46 Million |
| Other Investing Activities | 16.65 Thousand | 259.31 Million | 94.99 Thousand | 1.00 | -1.00 | 1.33 |
| Financing Cash Flow | -92.45 Million | -320.46 Million | -16.47 Million | -129.81 Million | 1.15 Million | -128.61 Million |
| Debt repayment | - | - | - | - | -130.96 Million | - |
| Dividends payments | - | -213.68 Million | -2.35 Million | -128.5 Million | -2.46 Million | -128.61 Million |
| Common Stock Repurchased | 118.54 Million | -118.54 Million | - | -3.8 Million | -3.8 Million | - |
| Common Stock Issuance | - | - | - | 4.85 Million | 4.85 Million | - |
| Other Financing Activities | -92.45 Million | -201.92 Million | -14.12 Million | -2.35 Million | 133.53 Million | -128.61 Million |
| Accounts receivables | - | 88.1 Million | - | 411.42 Million | 411.42 Million | -371.84 Million |
| Accounts payables | - | - | - | -56.23 Million | - | - |
| Inventory | - | -153.42 Million | - | -11.64 Million | -11.64 Million | -4.21 Million |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 2.07 Billion | 2.04 Billion | 1.96 Billion | 1.6 Billion | 1.49 Billion | 1.97 Billion |
| Cash at end of period | 1.81 Billion | 2.07 Billion | 2.04 Billion | 1.96 Billion | 1.96 Billion | 1.49 Billion |
| Capital Expenditure | -78.92 Million | -107.71 Million | -123.27 Million | -297.48 Million | -57.7 Million | -156.5 Million |
| Effect of forex changes on cash | 15.46 Thousand | 119.24 Thousand | -7.69 Million | 61.77 Thousand | -2.91 Million | -5.67 Million |
| Net cash flow / Change in cash | -255.42 Million | 26.1 Million | 76.9 Million | 367.97 Million | 475.1 Million | -483.15 Million |
| Free Cash Flow | 141.99 Million | 84.23 Million | 83.28 Million | 758.31 Million | 217.77 Million | 166.53 Million |
RUL
FFM
SALRY
KTCC
HAUP
AUVIQ